openPR Logo
Press release

Anti-Hypertensive Drugs Market to Perceive Phenomenal Growth of USD 41,123.2 million by 2023; Asserts MRFR Unleashing the forecast up to 2023 with Novartis AG, AstraZeneca, Daiichi Sankyo Company, Ltd. and more

02-12-2019 01:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Anti-Hypertensive Drugs Market

Anti-Hypertensive Drugs Market

Market Research Future (MRFR) in its recently published study report asserts that the already booming market of Anti-Hypertensive Drugs is expected to gain prominence over the forecast period.
The rising incidence of hypertension is closely related to sedentary lifestyle and unhealthy eating patterns. The expansion of the market is also effectively supported by the improved detection methods as well as the availability of better drugs for the treatment of the condition. Increased research and development activities to improve overall drug qualities such as its efficacy is expected to boost the progress of the market in the upcoming period.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2347

The market is projected to attain revenues touching $ 38.9 billion by 2022 while expanding at a CAGR of 2.73% approximately in the forecast period.

Competitive Analysis

The central contenders in the global anti- hypertensive drugs market are Astra Zeneca plc, Pfizer Inc., Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Takeda Pharmaceuticals Company Limited, Novartis AG and Ranbaxy Laboratories Limited, Inc.

Segmental Analysis

The segmentation of the anti-hypertensive drugs market is carried out on the basis of pharmacological class, hypertension type, region and disease source. On the basis of pharmacological class, the market is segmented into ACE Inhibitors, diuretics, adrenergic blocker, calcium channel blockers among others. The regions included in the market comprise of Europe, North America, Europe, Asia Pacific and rest of the world. On the basis of hypertension type, the anti-hypertensive drugs market is segmented into pulmonary hypertension drugs and systemic drugs. on the basis of disease source, the market is segmented into primary and secondary.

Regional Analysis

The regional analysis of the market comprises of Europe, North America, Europe, Asia Pacific and rest of the world. Globally, the North American region is the principal market for anti-hypertensive drugs. The European region is the next major market for anti-hypertensive drugs. The advanced regions will govern the approaching future market for anti-hypertensive drugs with emerging regions in a supporting role only. However, the emerging region's market especially the Asia Pacific region will be the swiftest rising and is expected to be central to the development of the market in the coming forecast period.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Hypertensive Drugs Market to Perceive Phenomenal Growth of USD 41,123.2 million by 2023; Asserts MRFR Unleashing the forecast up to 2023 with Novartis AG, AstraZeneca, Daiichi Sankyo Company, Ltd. and more here

News-ID: 1580858 • Views:

More Releases from Market Research Future

Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide. The Rise of
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols. The
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$